Clevira, an antiviral formulation received Government of India regulatory approval as a supportive treatment for mild to moderate COVID-19 cases.
Clevira
Leave a Comment / May 17, 2021 May 17, 2021
Clevira, an antiviral formulation received Government of India regulatory approval as a supportive treatment for mild to moderate COVID-19 cases.